235 related articles for article (PubMed ID: 23500659)
1. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats.
Atawia RT; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
Toxicol Lett; 2013 May; 219(2):160-9. PubMed ID: 23500659
[TBL] [Abstract][Full Text] [Related]
2. Modulatory Effect of Silymarin on Apoptosis in Testosterone -Induced Benign Prostatic Hyperplasia in Rats.
El-Ashmawy NE; Khedr EG; El-Bahrawy HA; Helmy NN
Pathol Oncol Res; 2020 Jul; 26(3):1947-1956. PubMed ID: 31902118
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.
Atawia RT; Mosli HH; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1131-40. PubMed ID: 25164963
[TBL] [Abstract][Full Text] [Related]
4. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
5. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
Wu X; Gu Y; Li L
Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
[TBL] [Abstract][Full Text] [Related]
6. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
[TBL] [Abstract][Full Text] [Related]
7. The effect of pomegranate fruit extract on testosterone-induced BPH in rats.
Ammar AE; Esmat A; Hassona MD; Tadros MG; Abdel-Naim AB; Guns ES
Prostate; 2015 May; 75(7):679-92. PubMed ID: 25620586
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of androgen and estrogen receptors in PCB (Aroclor 1254)-exposed rat ventral prostate: impact of alpha-tocopherol.
Selvakumar K; Sheerin Banu L; Krishnamoorthy G; Venkataraman P; Elumalai P; Arunakaran J
Exp Toxicol Pathol; 2011 Jan; 63(1-2):105-12. PubMed ID: 19932013
[TBL] [Abstract][Full Text] [Related]
9. Effect of sorghum ethyl-acetate extract on benign prostatic hyperplasia induced by testosterone in Sprague-Dawley rats.
Ryu JM; Jang GY; Park D; Woo KS; Kim TM; Jeong HS; Kim DJ
Biosci Biotechnol Biochem; 2018 Dec; 82(12):2101-2108. PubMed ID: 30124113
[TBL] [Abstract][Full Text] [Related]
10. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
11. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
12. Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis.
Zheng H; Xu W; Lin J; Peng J; Hong Z
Mol Med Rep; 2013 Mar; 7(3):848-54. PubMed ID: 23314795
[TBL] [Abstract][Full Text] [Related]
13. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
14. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
15. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
16. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
17. Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats.
Shoieb SM; Esmat A; Khalifa AE; Abdel-Naim AB
Food Chem Toxicol; 2018 Jan; 111():650-659. PubMed ID: 29247772
[TBL] [Abstract][Full Text] [Related]
18. Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective.
Mosli HH; Esmat A; Atawia RT; Shoieb SM; Mosli HA; Abdel-Naim AB
Sci Rep; 2015 Oct; 5():15639. PubMed ID: 26492952
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of 2-hydroxy-4-methoxy benzoic acid on testosterone induced benign prostatic hyperplasia in Wister rats.
Ali MI; Kondreddi HD; Veeresh B
Eur J Pharmacol; 2013 Jan; 698(1-3):397-403. PubMed ID: 23123055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
